34th Biennial Dermatology Symposium: The O'Leary Meeting 2025 - Livestream (virtual)
Course Directors:Afsaneh Alavi, M.D. and Rochelle R. Torgerson, M.D., Ph.D.
September 26 - 27, 2025 - Internet Live Activity - Rochester, Minnesota
Broadcast in Central Time
The 34th Biennial Dermatology Symposium: The O’Leary Meeting 2025 aims to provide an update on dermatological conditions, new therapeutics, and devices for the dermatologist and dermatological team. The 2025 meeting highlights dermatology crossing paths with other disciplines such as oncology, rheumatology, gastroenterology, surgery, and cosmetics. This symposium consists of a multimedia approach to updating physicians about the current and future care of dermatology patients with both common and rare diseases. Traditional lecture format and interactive panel formats with faculty representation from all three Mayo Clinic sites are used. The information presented is relevant to dermatopathologists, surgical dermatologists, general dermatologists, and pediatric dermatologists.
Target Audience
his course is designed for dermatologists, physician assistants, nurses and other healthcare practitioners in dermatology or the other highlighted specialty areas of care. A special welcome to the alumni from the Mayo Clinic Dermatology Department alumni from Arizona, Florida, and Minnesota.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify the implementation of interdisciplinary care in patients with dermatological conditions.
- Evaluate the emerging therapies in psoriatic arthritis.
- Identify practical trips in cosmetic dermatology.
- Assess practical clinical pearls to help diagnose dermatological diseases.
- Summarize advances in the diagnosis of cross-specialty diseases.
- Summarize improving care of pediatric dermatology patients by increasing comfort with the appropriate use of JAK inhibitors in children.
- Identify the cutting-edge use of skin imaging and artificial intelligence to improve the diagnosis of skin cancers.
- Examine the appropriate use of Mohs; avoiding over and under use.
- Identify the newer family of autoinflammatory diseases to broaden the differential diagnosis list when faced with challenging rashes.
- Analyze updated guidance on the management of cutaneous adverse drug reactions.
- Evaluate the emerging therapies in pediatric populations.
- Evaluate emerging therapies in dermatology surgical cases.
- Assess practical clinical pearls to help treat dermatological diseases.
- Summarize advances in the management of cross-specialty diseases.
- Identify the cutting-edge use of skin imaging and artificial intelligence to improve the management of skin cancers.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
View Program on Main Course page
Broadcast in Central Time
Broadcast in Central Time
All travel and lodging expenses are the sole responsibility of the individual registrant.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 13.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 13.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
IPCE
This activity was planned by and for the healthcare team, and learners will receive 13.50 Interprofessional Continuing Education (IPCE) credit for learning and change.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 13.50 AAPA Category 1
- 13.50 AMA PRA Category 1 Credit™
- 13.50 ANCC
- 13.50 Attendance
- 13.50 IPCE
Price
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.